米非司酮治疗宫内残留的疗效与B超及病理检查的对照研究(1)
 |
| 第1页 |
参见附件(1251KB，2页)。
[摘要] 目的:研究米非司酮治疗宫内残留的疗效与其B超及病理检查的关系。方法:160例宫内残留者均采用米非司酮治疗,按治疗前B超检查宫内残留物大小分为<20 mm组68例、20～30 mm组54例、>30 mm组38例三组,记录三组排出物或刮出物大小及病理组织的结果,观察其治疗效果与B超及排出物病理检查的关系。结果:三组疗效分别为97.06%、85.19%、57.89%,两两比较有显著性差异(P<0.05);治疗前B超检查宫内残留物大小与排出物或刮出物大小符合率分别为100.00%、98.15%、97.06%,两两比较无显著性差异(P>0.05)。病理结果:胚胎组织占多数为85%,余为陈旧性血块伴炎性细胞占15%,此两种类型疗效分别为80.88%、100.00%,两者之间比较有显著性差异(P<0.05)。结论:胚胎残留及残留物的大小是影响米非司酮疗效的主要因素,B超是指导治疗的重要检查手段,对残留物直径>30 mm者,要密切观察临床症状,必要时及时行刮宫术,治疗的同时要抗感染治疗。
[关键词] 米非司酮;宫内残留;B超;病理;对照研究
[中图分类号] R445.1[文献标识码]A [文章编号]1673-7210(2010)06(b)-026-02
Control study on the residual effect of mifepristone treatment of intrauterine and the B-ultrasonography and pathological examination
LI Qiuyue, TONG Ganyi, HUANG Huihong
(The People's Hospital of Huiyang District in Huizhou City, Huizhou 516211, China)
[Abstract] Objective: To study the relationship between the efficacy of mifepristone on the treatment of intrauterine residue and B-ultrasonography or pathological detection. Methods: 160 cases of patients with residual caught intrauterine were treated with mifepristone, were divided into three groups by B-ultrasonography before treatment of intrauterine residue size: 68 cases <20 mm, 54 cases was 20-30 mm, 38 cases >30 mm, the discharges or scrapings size and pathology results of three groups were recorded, and the relationship between the efficacy of mifepristone and B-ultrasonography or pathological detection were observed. Results: The efficacy of the three groups were 97.06%, 85.19%, 57.89%, there were significant differences(P<0.05); the coincidence of the size of intrauterine residue used by B-ultrasonography and the size of discharges or scrapings were 100.00%, 98.15%, 97.06% respectively, there was no significant difference (P>0.05). Pathology results: embryonic tissue, the majority was 85%, more than the old blood clots associated with inflammatory cells (15%), the efficacy of the two groups were 80 ......
您现在查看是摘要介绍页，详见PDF附件(1251KB，2页)。